YOLFTbeta
Daewoong Pharma

Daewoong Pharma

069620 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

101,900.00KRW-600.00 (-0.59%)

Price History

Full chart

Market Stats

Previous Close102,500.00
Open101,000.00
Day Range100,400.00 – 102,900.00
52-Week Range104,900.00 – 198,713.20
Volume17.64K
Market Cap1.26T
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.56%
Beta0.03
50-Day Avg118,642.00
200-Day Avg143,917.00

About

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Chang-Jae Lee
  • Employees1.89K
  • Headquarters12, Bongeunsa-ro 114-gil, Seoul, South Korea, 135-715, Korea
  • Websitehttps://www.daewoong.com

Leadership

  • Mr. Chang-Jae LeeCEO & Executive Director · b. 1977
  • Mr. Seongsoo ParkCEO & Executive Director · b. 1976
  • Eunkyeong ParkExecutive Director

Financials

Income Statement

Currency: KRW2007-12-312008-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue484.35B548.33B710.55B669.01B682.51B735.89B839.69B883.92B960.31B1.03T1.11T1.06T1.15T1.28T1.38T1.42T1.57T
Growth (%)-+13.21%+29.58%-5.85%+2.02%+7.82%+14.10%+5.27%+8.64%+7.41%+7.95%-5.21%+9.24%+11.03%+7.44%+3.44%+10.42%
Cost of Revenue216.75B286.63B398.50B379.31B377.40B452.90B538.15B510.23B553.33B621.48B635.13B608.48B608.23B641.13B687.16B688.52B748.36B
Gross Profit----290.31B269.41B301.54B373.69B406.98B409.94B478.29B446.94B544.75B638.96B688.17B734.17B822.53B
Gross Margin----42.54%36.61%35.91%42.28%42.38%39.75%42.96%42.35%47.25%49.91%50.04%51.60%52.36%
Operating Expense----218.94B217.46B257.97B347.79B368.03B385.38B433.61B429.96B455.84B543.16B565.57B586.23B625.75B
Operating Income73.40B41.98B59.29B36.88B71.37B51.94B43.56B25.89B38.96B24.57B44.69B16.98B88.90B95.80B122.59B147.94B196.78B
Operating Margin15.15%7.66%8.34%5.51%10.46%7.06%5.19%2.93%4.06%2.38%4.01%1.61%7.71%7.48%8.91%10.40%12.53%
EBITDA--------84.51B60.27B73.61B65.05B71.07B86.43B179.40B112.52B255.38B
EBITDA Margin--------8.80%5.84%6.61%6.16%6.16%6.75%13.04%7.91%16.26%
Net Income58.95B32.93B50.19B34.08B58.40B31.54B42.93B26.97B31.58B-15.15B22.01B12.75B24.66B42.24B121.74B24.73B195.86B
Net Income Margin12.17%6.01%7.06%5.09%8.56%4.29%5.11%3.05%3.29%-1.47%1.98%1.21%2.14%3.30%8.85%1.74%12.47%
R&D--19.52B-14.72B18.74B31.07B103.69B107.94B113.81B109.44B115.22B127.27B163.60B171.57B171.29B180.31B
R&D as % of Total Revenue--2.75%-2.16%2.55%3.70%11.73%11.24%11.03%9.83%10.92%11.04%12.78%12.48%12.04%11.48%
Interest Expense0000000009.60B10.09B10.61B10.25B8.41B13.60B6.99B12.48B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.93%0.91%1.01%0.89%0.66%0.99%0.49%0.79%

Balance Sheet

Currency: KRW2007-12-312008-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets392.81B486.24B498.46B482.34B579.01B694.26B944.53B1.14T1.21T1.21T1.25T1.37T1.42T1.56T1.57T1.98T2.36T
Total Liabilities123.24B207.39B136.04B95.76B141.05B238.76B364.29B540.15B581.99B600.04B609.75B671.66B712.77B822.12B762.77B1.05T1.23T
Total Equity263.76B273.25B358.45B383.24B433.67B443.08B480.07B499.49B519.44B494.13B519.31B550.99B573.57B608.02B802.97B794.64B1.01T
Cash28.42B35.59B55.16B50.56B67.66B63.65B59.94B78.28B91.12B65.33B32.09B72.30B75.91B102.95B17.22B102.95B168.94B
Net Debt--------293.94B321.52B356.44B365.84B361.79B335.56B416.97B543.02B658.39B

Cash Flow

Currency: KRW2007-12-312008-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow25.81B31.33B78.82B45.02B54.16B25.95B35.89B15.38B103.94B47.50B57.60B100.98B39.99B118.21B132.57B51.49B149.21B
Investing Cash Flow-----63.50B-129.45B-108.59B-155.77B-73.00B-68.62B-85.61B-127.15B-87.68B-106.87B---
Financing Cash Flow2.81B47.92B--26.59B99.51B67.86B159.15B-16.69B-4.78B-5.66B66.59B50.22B15.52B---
Capital Expenditure35.89B35.35B40.92B23.77B19.04B46.00B95.13B163.25B69.12B56.99B22.31B26.49B29.09B65.23B118.67B229.00B241.37B
Free Cash Flow--------7.18B-9.56B7.49B41.28B-34.80B4.91B13.89B-177.51B-92.16B
Dividends Paid7.30B7.30B5.72B7.78B8.02B8.26B7.22B7.22B6.19B6.19B6.19B6.19B6.46B8.07B6.64B7.74B8.08B
FCF to OCF--------6.91%-20.13%13.01%40.88%-87.01%4.15%10.48%-344.73%-61.77%
Dividend Paid to FCF--------86.21%-64.76%82.64%15.00%-18.56%164.41%47.80%-4.36%-8.76%

Earnings

Report DateNov 3, 2004Feb 13, 2005May 11, 2005Feb 8, 2006Apr 26, 2006Jul 20, 2006Oct 30, 2006Feb 5, 2007Jul 30, 2007Oct 23, 2007Jan 23, 2008Apr 28, 2008Jul 25, 2008Dec 14, 2008Jul 10, 2009Nov 2, 2009Feb 12, 2010Jun 29, 2010Oct 22, 2010Feb 10, 2011Jun 1, 2011Jul 22, 2011Nov 10, 2011Jan 26, 2012May 29, 2013Jul 19, 2013Nov 7, 2013Jan 30, 2014May 28, 2014Jul 30, 2014Dec 1, 2014Feb 9, 2015May 8, 2015Aug 17, 2015Oct 30, 2015Mar 30, 2016May 16, 2016Aug 16, 2016Oct 28, 2016Feb 9, 2017May 15, 2017Jul 25, 2017Nov 1, 2017Feb 20, 2018May 8, 2018Aug 6, 2018Nov 14, 2018Mar 5, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Feb 19, 2020May 15, 2020Aug 14, 2020Nov 16, 2020Mar 11, 2021May 5, 2021Jul 29, 2021Nov 15, 2021Feb 15, 2022May 16, 2022Aug 16, 2022Oct 31, 2022Feb 15, 2023May 3, 2023Jul 26, 2023Oct 26, 2023Feb 5, 2024Apr 29, 2024Aug 8, 2024Oct 30, 2024Feb 10, 2025Apr 28, 2025Aug 7, 2025Oct 28, 2025Mar 24, 2026Apr 27, 2026Aug 18, 2026
EPS Estimate621.20569.26630.44673.24678.20730.73811.101107.861144.001628.061403.014571.811348.855882.47414.34867.891135.251300.08-----------1394.001290.37----920.00822.00--923.38549.65521.18856.64948.10749.37835.00590.14808.82497.411546.76774.99881.76549.26369.78754.382403.65342.74732.781481.522107.491140.861795.011843.132226.981386.281325.781524.49-204.001466.982224.462341.002375.272329.77-----
EPS Actual697.81439.70572.48813.901006.60883.581542.431298.151117.401381.441612.051139.811197.60906.158.63867.891135.251300.08408.98212.121323.381696.351404.19597.921190.001637.941925.08940.501194.461434.00-548.00976.181098.631241.921010.171159.00410.00428.84398.091513.001512.791109.00869.37763.00269.00549.00318.00-2605.00567.001108.00153.00304.0065.00-732.00223.001647.00-2139.00553.00991.002770.931230.001578.001852.00-844.621379.002150.001354.005737.24708.0099.002458.00-1115.101903.003281.324029.587807.902251.032899.86
Surprise12.33%-22.76%-9.19%20.89%48.42%20.92%90.17%17.18%-2.33%-15.15%14.90%-75.07%-11.21%-84.60%-97.92%0.00%0.00%0.00%-----------2.87%-142.47%----25.98%-50.12%--63.85%175.23%112.79%1.49%-19.52%-64.10%-34.25%-46.11%-422.07%13.99%-28.37%-80.26%-65.52%-88.17%-297.96%-70.44%-31.48%-724.09%-24.53%-33.11%31.48%7.81%-12.09%0.48%-137.93%-0.53%62.17%-11.18%2912.37%-51.74%-95.55%5.00%-146.95%-18.32%-----
TimingAfter-hoursAfter-hoursPre-market-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hours-----------Pre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-Pre-marketAfter-hoursPre-market-Pre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap1.26T
Enterprise Value1.99T
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.77
Price / Book1.15
Revenue (TTM)1.64T
Gross Profit (TTM)854.64B
EBITDA256.82B
Profit Margin11.95%
Operating Margin15.18%
Return on Equity16.64%
Return on Assets5.09%
Shares Outstanding11.51M
Shares Float5.38M
Beta0.03
Dividend Yield0.56%
Dividend Rate600.00
Payout Ratio3.53%

Dividends

20251×
600.00Dec 29, 2025
20241×
600.00Dec 27, 2024
20221×
600.00Dec 28, 2022
20211×
600.00Dec 29, 2021
20201×
600.00Dec 29, 2020
20191×
600.00Dec 27, 2019
20181×
600.00Dec 27, 2018
20171×
600.00Dec 27, 2017
20161×
600.00Dec 28, 2016
20151×
700.00Dec 29, 2015
20141×
700.00Dec 29, 2014
20131×
800.00Dec 27, 2013
20121×
776.70Dec 27, 2012
20111×
754.08Dec 28, 2011
20102×
549.09Dec 29, 2010710.79Mar 30, 2010
20091×
646.96Mar 30, 2009
20081×
669.99Mar 28, 2008
20071×
669.99Mar 29, 2007
20061×
586.24Mar 30, 2006
20051×
565.30Mar 30, 2005
20041×
523.43Mar 30, 2004
20031×
418.74Mar 28, 2003

Stock Splits

  • Dec 27, 20121.03:1
  • Dec 28, 20111.03:1
  • Dec 29, 20101.03:1
  • Mar 31, 20101.03:1
  • Mar 31, 20091.03:1
  • Mar 31, 20081.03:1